Article
Costing ‘the’ MTD … in 2-D
2018-07-17
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> I have previously evaluated the efficiency of one-size-fits-all dosing for single agents in oncology (Norris 2017b). By means of a generic argument based on an E max -type dose-response model, I showed that one-size-fits-all dosing may roughly halve a drug’s value to society. Since much of the past decade’s ‘innovation’ in oncology dose-finding methodology has involved the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ae1d82de-c1be-525a-b947-212ee8abbdca
- DOI
- 10.1101/370817
